|Net Assets||19.59 Mil|
- Last NAV update 7/29/2014 4:00 PM ET
|The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. BiotechnologySM Index. The fund invests in securities and derivatives that the adviser believes, in combination, should have similar daily return characteristics as one and one-half times (1.5x) the daily return of the index. The index measures the performance of the biotechnology sector of the U.S. equity market. It is non-diversified.|
- Year to date performance as of 7/29/2014 12:00 AM ET
|Fund Manager||Michael Neches|
|Minimum Initial Purchase||15,000.00|
|Minimum IRA Investment||15,000.00|
- * Annualized returns
- Performance as of 7/29/2014 12:00 AM ET
|Net Assets||19.59 Mil||30.99 Mil|
|Avg Market Cap||49.54 Bil||NA|
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.